tiprankstipranks
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market
Holding SABS?
Track your performance easily

SAB Biotherapeutics (SABS) Technical Analysis

85 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
SAB Biotherapeutics’s (SABS) Moving Averages Convergence Divergence (MACD) indicator is 0.22, suggesting SAB Biotherapeutics is a Sell.
SAB Biotherapeutics’s (SABS) 20-Day exponential moving average is 3.25, while SAB Biotherapeutics’s (SABS) share price is $3.42, making it a Sell.
SAB Biotherapeutics’s (SABS) 50-Day exponential moving average is 3.02, while SAB Biotherapeutics’s (SABS) share price is $3.42, making it a Buy.

SAB Biotherapeutics (SABS) Pivot Points

Nov 22, 2024, 09:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.51
2.90
3.21
3.60
3.91
4.30
4.61
Fibonacci
2.90
3.17
3.34
3.60
3.87
4.04
4.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SAB Biotherapeutics (SABS) Moving Averages

Nov 22, 2024, 09:17 AM
Period
Simple
Exponential
MA5
3.61Sell
3.46Sell
MA10
3.52Sell
3.43Sell
MA20
3.18Buy
3.25Sell
MA50
2.91Buy
3.02Buy
MA100
2.84Buy
3.13Buy
MA200
3.62Sell
4.04Sell
SAB Biotherapeutics’s (SABS) 10-Day exponential moving average is 3.43, while SAB Biotherapeutics’s (SABS) share price is $3.42, making it a Sell.
SAB Biotherapeutics’s (SABS) 100-Day exponential moving average is 3.13, while SAB Biotherapeutics’s (SABS) share price is $3.42, making it a Buy.
SAB Biotherapeutics’s (SABS) stock price is $3.42 and SAB Biotherapeutics’s (SABS) 50-day simple moving average is 2.91, creating a Buy signal.
SAB Biotherapeutics’s (SABS) stock price is $3.42 and SAB Biotherapeutics’s (SABS) 100-day simple moving average is 2.84, creating a Buy signal.
SAB Biotherapeutics’s (SABS) stock price is $3.42 and SAB Biotherapeutics’s (SABS) 200-day simple moving average is 3.62, creating a Sell signal.

SAB Biotherapeutics (SABS) Technical Indicators

Nov 22, 2024, 09:17 AM
Name
Value
Implied Action
RSI (14)
50.44
Neutral
STOCH (9,6)
33.76
Neutral
STOCHRSI (14)
40.87
Neutral
MACD (12,26)
0.22
Sell
ADX (14)
28.47
Neutral
Williams %R
-66.67
Buy
CCI (14)
22.94
Neutral
ATR (14)
0.40
-
Ultimate Oscillator
43.80
Neutral
ROC
11.93
Buy
SAB Biotherapeutics’s (SABS) Relative Strength Index (RSI) is 50.44, creating a Neutral signal.
SAB Biotherapeutics’s (SABS) Trend Strength Indicator (ADX) is 28.47, creating a Neutral signal.
SAB Biotherapeutics’s (SABS) Commodity Channel Index (CCI) is 22.94, creating a Neutral signal.
SAB Biotherapeutics’s (SABS) Price Rate of Change (ROC) is 11.93, creating a Buy signal.

FAQ

Is SABS a Buy, Hold, or Sell?
Based on SABS’s technical indicators, SABS is a Hold.
    What is SABS’s RSI (14)?
    SABS’s RSI (14) is 50.44, which suggests SABS is a Neutral.
      What is SABS’s MACD?
      SABS’s MACD is 0.22, which suggests SABS is a Sell.
        What is SABS’s 5-day moving average?
        SABS’s 5-day moving average is 3.61, which suggests SABS is a Sell.
          What is SABS’s 20-day moving average?
          SABS 20-day moving average is 3.18, which suggests SABS is a Buy.
            What is SABS’s 50-day moving average?
            SABS’s 50-day moving average is 2.91, which suggests SABS is a Buy.
              What is SABS’s 200-day moving average?
              SABS’s 200-day moving average is 3.62, which suggests SABS is a Sell.
                What is SABS’s Williams % R (14)?
                SABS’s Williams % R (14) is -66.67, which suggests SABS is a Buy.
                  What is SABS’s CCI (14)?
                  SABS’s CCI (14) is 22.94, which suggests SABS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis